Medinotec (MDNC) Net Equity Issued and Repurchased (2022 - 2023)

Medinotec (MDNC) posted Net Equity Issued and Repurchased of -$169375.0 for Q1 2023, down 200.0% on a QoQ basis from $169375.0 in Q3 2022, and down 1793.75% year-over-year from $10000.0 in Q1 2022.

Medinotec (MDNC) Net Equity Issued and Repurchased (2022 - 2023) Analysis & Trends

Medinotec's Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at -$169375.0 for Q1 2023.

  • Quarterly Net Equity Issued and Repurchased fell 1793.75% year-over-year to -$169375.0 in Q1 2023, while the trailing twelve-month figure through Feb 2023 was $3.3 million (changed N/A YoY) and the FY2023 annual result came in at $3.3 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased was -$169375.0 for Q1 2023 at Medinotec, down from $169375.0 in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $3.3 million in Q2 2022 and bottomed at -$169375.0 in Q1 2023.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 97.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 12.70 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Medinotec 58.78 Mn 58.19 Mn 1.31 Mn -

Historic Data

Download Data
DateValue
Feb 28, 2023 -169,375.00
Feb 28, 2023 -169,375.00
Aug 31, 2022 169,375.00
Aug 31, 2022 169,375.00
May 31, 2022 3.30 Mn
May 31, 2022 3.30 Mn
Feb 28, 2022 10,000.00
Feb 28, 2022 10,000.00